These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 32151075)
1. Opipramol Inhibits Lipolysis in Human Adipocytes without Altering Glucose Uptake and Differently from Antipsychotic and Antidepressant Drugs with Adverse Effects on Body Weight Control. Carpéné C; Les F; Mercader J; Gomez-Zorita S; Grolleau JL; Boulet N; Fontaine J; Iglesias-Osma MC; Garcia-Barrado MJ Pharmaceuticals (Basel); 2020 Mar; 13(3):. PubMed ID: 32151075 [TBL] [Abstract][Full Text] [Related]
2. The anxiolytic drug opipramol inhibits insulin-induced lipogenesis in fat cells and insulin secretion in pancreatic islets. Iglesias-Osma MC; García-Barrado MJ; Hernandez-Gonzalez D; Perrier K; Viana P; Carpéné C J Physiol Biochem; 2023 May; 79(2):415-425. PubMed ID: 36821072 [TBL] [Abstract][Full Text] [Related]
3. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors. Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478 [TBL] [Abstract][Full Text] [Related]
4. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats. Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the antilipolytic response of human adipocytes to tyramine, a trace amine present in food. Carpéné C; Galitzky J; Belles C; Zakaroff-Girard A J Physiol Biochem; 2018 Nov; 74(4):623-633. PubMed ID: 30039351 [TBL] [Abstract][Full Text] [Related]
6. Multiple Direct Effects of the Dietary Protoalkaloid Carpéné C; Viana P; Fontaine J; Laurell H; Grolleau JL Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956295 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of rat fat cell lipolysis by monoamine oxidase and semicarbazide-sensitive amine oxidase substrates. Visentin V; Prévot D; Marti L; Carpéné C Eur J Pharmacol; 2003 Apr; 466(3):235-43. PubMed ID: 12694806 [TBL] [Abstract][Full Text] [Related]
8. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes. Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035 [TBL] [Abstract][Full Text] [Related]
9. The amine oxidase inhibitor phenelzine limits lipogenesis in adipocytes without inhibiting insulin action on glucose uptake. Carpéné C; Grès S; Rascalou S J Neural Transm (Vienna); 2013 Jun; 120(6):997-1003. PubMed ID: 23242743 [TBL] [Abstract][Full Text] [Related]
10. Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties. Les F; Deleruyelle S; Cassagnes LE; Boutin JA; Balogh B; Arbones-Mainar JM; Biron S; Marceau P; Richard D; Nepveu F; Mauriège P; Carpéné C Chem Biol Interact; 2016 Oct; 258():115-25. PubMed ID: 27475863 [TBL] [Abstract][Full Text] [Related]
11. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes. Morin N; Lizcano JM; Fontana E; Marti L; Smih F; Rouet P; Prévot D; Zorzano A; Unzeta M; Carpéné C J Pharmacol Exp Ther; 2001 May; 297(2):563-72. PubMed ID: 11303044 [TBL] [Abstract][Full Text] [Related]
12. Dual action of octopamine on glucose transport into adipocytes: inhibition via beta3-adrenoceptor activation and stimulation via oxidation by amine oxidases. Visentin V; Morin N; Fontana E; Prévot D; Boucher J; Castan I; Valet P; Grujic D; Carpéné C J Pharmacol Exp Ther; 2001 Oct; 299(1):96-104. PubMed ID: 11561068 [TBL] [Abstract][Full Text] [Related]
13. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment. Minet-Ringuet J; Even PC; Valet P; Carpéné C; Visentin V; Prévot D; Daviaud D; Quignard-Boulange A; Tomé D; de Beaurepaire R Mol Psychiatry; 2007 Jun; 12(6):562-71. PubMed ID: 17211438 [TBL] [Abstract][Full Text] [Related]
15. High doses of tyramine stimulate glucose transport in human fat cells. Carpéné C; Les F; Mercader-Barceló J; Boulet N; Briot A; Grolleau JL J Physiol Biochem; 2022 May; 78(2):543-556. PubMed ID: 35066863 [TBL] [Abstract][Full Text] [Related]
16. Effects of Chemical Structures Interacting with Amine Oxidases on Glucose, Lipid and Hydrogen Peroxide Handling by Human Adipocytes. Carpéné C; Viana P; Iffiú-Soltesz Z; Tapolcsányi P; Földi AÁ; Mátyus P; Dunkel P Molecules; 2022 Sep; 27(19):. PubMed ID: 36234761 [TBL] [Abstract][Full Text] [Related]
17. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide. Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994 [TBL] [Abstract][Full Text] [Related]
18. Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in Adipocytes. Gomez-Zorita S; Belles C; Briot A; Fernández-Quintela A; Portillo MP; Carpéné C Phytother Res; 2017 Aug; 31(8):1273-1282. PubMed ID: 28627722 [TBL] [Abstract][Full Text] [Related]
19. Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes. Carpéné C; Daviaud D; Boucher J; Bour S; Visentin V; Grès S; Duffaut C; Fontana E; Testar X; Saulnier-Blache JS; Valet P Metabolism; 2006 Oct; 55(10):1397-405. PubMed ID: 16979412 [TBL] [Abstract][Full Text] [Related]
20. Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells. Carpéné C; Garcia-Vicente S; Serrano M; Marti L; Belles C; Royo M; Galitzky J; Zorzano A; Testar X World J Diabetes; 2017 Apr; 8(4):143-153. PubMed ID: 28465791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]